Clinical Trial Update: A Phase 2 Study of QLM3003 Ointment in Participants With Mild or Moderate Atopic Dermatitis [Phase 2]

View source ↗

Summary

Phase 2 study of QLM3003 Ointment in participants with mild-to-moderate atopic dermatitis has completed. The available snippet notes completion but does not inc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• QLM3003 Ointment

Snippet

Sponsor: Qilu Pharmaceutical Co., Ltd. | Conditions: Atopic Dermatitis | Phase 2 | Status: COMPLETED